Table 1. Patient characteristics.
| Risk (WHO) | Stage (TNM) | Myasthenia gravis | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| LRT | HRT | early | advanced | No | Yes | |||||
| (n = 34) | (n = 28) | p-value | (n = 49) | (n = 13) | p-value | (n = 48) | (n = 14) | p-value | ||
| Characteristic | ||||||||||
| Age (y), mean ± SD | 58.8 ± 14.8 | 54.0 ± 12.4 | 0.182 | 57.5 ± 14.6 | 53.3 ± 10.8 | 0.334 | 57.4 ± 14.4 | 53.9 ± 12.3 | 0.410 | |
| Sex (n) | 0.661 | 0.816 | 0.052 | |||||||
| female | 14 | 14 | 23 | 5 | 18 | 10 | ||||
| male | 20 | 14 | 26 | 8 | 30 | 4 | ||||
| Diameter (mm), mean ± SD | 71.8 ± 34.9 | 79.2 ± 32.7 | 0.130 | 71.0 ± 34.1 | 90.6 ± 29.1 | 0.011 | 78.6 ± 35.3 | 63.0 ± 25.7 | 0.062 | |
| TNM Stage (IASLC/ITMIG) | 0.001 | - | 0.673 | |||||||
| I | 32 | 17 | 49 | 0 | 37 | 12 | ||||
| II | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| III | 2 | 2 | 0 | 4 | 3 | 1 | ||||
| IV | 0 | 9 | 0 | 9 | 8 | 1 | ||||
| WHO Type | - | <0.001 | <0.001 | |||||||
| A | 10 | 0 | 10 | 0 | 10 | 0 | ||||
| AB | 16 | 0 | 16 | 0 | 15 | 1 | ||||
| B1 | 8 | 0 | 6 | 2 | 7 | 1 | ||||
| B2 | 0 | 13 | 11 | 2 | 5 | 8 | ||||
| B3 | 0 | 9 | 5 | 4 | 5 | 4 | ||||
| C | 0 | 6 | 1 | 5 | 6 | 0 | ||||
IASLC: International Association for the Study of Lung Cancer. ITMIG: International Thymic Malignancy Interest Group. TNM: Tumor-node-metastasis. WHO: World Health Organization. SD: Standard deviation. P-values were derived from t-tests (age), Mann-Whitney U tests (diameter), or chi-squared tests for independence (categorical variables).